Outcomes After Direct-Acting Antiviral Therapy Based on Donor Hepatitis C Serostatus Among Hepatitis C Virus-Infected Kidney Transplant Recipients

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
Mai SedkiKalyan Ram Bhamidimarri

Abstract

Renal grafts from hepatitis C virus-positive deceased donors, which were once discarded, can now be transplanted into recipients and treated posttransplant due to the emergence of direct-acting antivirals, significantly improving wait list time and organ shortages. Here, we compared outcomes in hepatitis C virus-positive patients who received kidneys from hepatitis C virus-positive versus -negative donors. In this single-center retrospective study, we divided 52 kidney transplant recipients who were viremic for hepatitis C virus pretransplant into 2 groups based on donors' hepatitis C virus serostatus (positive/negative). Demographics, time to transplant, efficacy of direct-acting antivirals, rejection episodes, immunosuppression adjustments, and renal function were assessed in both groups. Our cohort included 50 patients receiving kidneys from deceased donors and 2 from living donors (1 related, 1 unrelated). Recipients of hepatitis C virus-positive kidneys had significantly less wait list time (36 days) than recipients of hepatitis C virus-negative kidneys (806 days; P < .001). All recipients responded well to direct-acting antivirals, with both groups showing similar sustained virologic response rates that were comparable to...Continue Reading

References

Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P MathurinM O Bitker
Sep 6, 2000·Kidney International·H U Meier-KriescheB Kaplan
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Kevin C AbbottThomas G Peters
Jan 9, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ihab M MahmoudMohamed A Sobh
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fabrizio FabriziGareth Dulai
Sep 8, 2006·European Journal of Gastroenterology & Hepatology·Patrizia BurraSavina Maria Luciana Aversa
Jul 5, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J M GloorF G Cosio
Jul 30, 2008·Journal of Hepatology·Paul Martin, Fabrizio Fabrizi
Jun 8, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K EllingsonUNKNOWN Organ Procurement Organization Nucleic Acid Testing Yield Project Team
Apr 11, 2014·Journal of Viral Hepatitis·F FabriziP Messa
Jul 23, 2015·The New England Journal of Medicine·Peter P ReeseDavid S Goldberg
Aug 28, 2015·Advances in Chronic Kidney Disease·Anu Gupta, Richard J Quigg
Mar 2, 2016·Current Opinion in Organ Transplantation·Tianyan Chen, Norah A Terrault
Mar 24, 2017·Transplant International : Official Journal of the European Society for Organ Transplantation·Kalyan R BhamidimarriDavid Roth
May 2, 2017·The New England Journal of Medicine·David S GoldbergPeter P Reese
Oct 23, 2017·Kidney International·Deirdre SawinskiJayme E Locke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Transplant Infectious Disease : an Official Journal of the Transplantation Society
Peng-Sheng TingPo-Hung Chen
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Marina Berenguer
© 2021 Meta ULC. All rights reserved